The Beauty Health Company (SKIN) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
The Beauty Health Company (SKIN) Earnings Overview
As of June 21, 2026, The Beauty Health Company (SKIN) reported trailing twelve-month net income of -$6M, reflecting +55.6% year-over-year growth. The company earned $-0.05 per diluted share over the past four quarters, with a net profit margin of -3.2%.
Looking at the long-term picture, SKIN's historical earnings data spans multiple years. The company achieved its highest annual net income of $44M in fiscal 2022.
The Beauty Health Company is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ELF ($55M net income, 3.3% margin), IPAR ($201M net income, 11.3% margin), COTY (-$536M net income, -6.2% margin), SKIN has room to improve margins relative to the peer group. Compare SKIN vs ELF →
SKIN Earnings vs Peers
Earnings metrics vs comparable public companies
SKIN Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$10M | +67.3% | -$21M | $-0.16 | -3.2% | -6.9% |
| 2024 | -$29M | +70.9% | -$68M | $-0.36 | -8.7% | -20.3% |
| 2023 | -$100M | -326.4% | -$131M | $-0.76 | -25.2% | -32.9% |
| 2022 | $44M | +111.7% | -$26M | $-0.23 | 12.1% | -7.1% |
| 2021 | -$379M | -1198.2% | -$40M | $-3.67 | -145.6% | -15.4% |
| 2020 | -$29M | -1681.1% | -$17M | $-0.85 | -24.5% | -14.4% |
| 2019 | -$2M | - | $13M | $-0.05 | -1.0% | 8.1% |
Download Data
Export SKIN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SKIN — Frequently Asked Questions
Quick answers to the most common questions about buying SKIN stock.
What is SKIN earnings per share (EPS)?
SKIN trailing twelve-month (TTM) diluted EPS is $-0.05, reflecting +55.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is The Beauty Health Company's net income?
The Beauty Health Company (SKIN) trailing twelve-month net income is $-6M as of 2025. Earnings grew +55.6% year-over-year.
Is SKIN profitable?
SKIN is not currently profitable on a TTM basis, reporting a net loss of $-6M. Net margin is -3.2%. Investors should monitor for a return to profitability.
What is SKIN's earnings growth rate?
SKIN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are SKIN's profit margins?
The Beauty Health Company net profit margin is -3.2%, operating margin is -6.9%, and gross margin is +65.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -16.9%.
Is SKIN growing earnings?
Yes, SKIN earnings are accelerating — EPS growth of +55.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-6M. Earnings momentum is strengthening.
What was SKIN's best earnings year?
The Beauty Health Company's highest annual net income on record is $44M, achieved in fiscal year 2022. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were SKIN's earnings last quarter?
SKIN's most recent reported quarter was Q1 2026. Net income was $-7M with diluted EPS of $-0.05. For a full breakdown of all quarters, see the quarterly earnings table on this page.